Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer

Longer mean duration of quality-adjusted time without symptoms of disease progression or toxicity of treatment seen with dostarlimab
uterus cancer endometrial malignant tumor
Adobe Stock
Medically Reviewed By:
Farrokh Sohrabi, M.D.
Published on
Updated on
Loading content, please wait...

Related Stories

No stories found.
logo
www.healthday.com